Publications of Tiago Fleming Outeiro
All genres
Journal Article (129)
21.
Journal Article
168 (8), pp. 1608 - 1624 (2024)
Is it all the RAGE? Defining the role of the receptor for advanced glycation end products in Parkinson's disease. Journal of Neurochemistry 22.
Journal Article
168 (8), pp. 1514 - 1526 (2024)
Altered hippocampal doublecortin expression in Parkinson's disease. Journal of Neurochemistry 23.
Journal Article
168 (8), pp. 1625 - 1639 (2024)
PrP meets alpha-synuclein: Molecular mechanisms and implications for disease. Journal of Neurochemistry 24.
Journal Article
14 (5), pp. 917 - 924 (2024)
Diabetes and Parkinson's Disease: Understanding Shared Molecular Mechanisms. Journal of Parkinson's Disease 25.
Journal Article
23 (7), p. 669 (2024)
Abandon the NAC in α-synuclein. Lancet Neurology 26.
Journal Article
18, 1412450 (2024)
Age-related alterations in efferent medial olivocochlear-outer hair cell and primary auditory ribbon synapses in CBA/J mice. Frontiers in Cellular Neuroscience 27.
Journal Article
14 (4), pp. 681 - 692 (2024)
Automated Capillary Electrophoresis Immunoblot for the Detection of Alpha-Synuclein in Mouse Tissue. Journal of Parkinson's Disease: JPD 28.
Journal Article
39 (6), pp. 1080 - 1081 (2024)
Reply to: “Rethinking Parkinson's Disease: A Syndromic Perspective”. Movement Disorders 29.
Journal Article
39 (6), pp. 929 - 933 (2024)
Basic Science in Movement Disorders: Fueling the Engine of Translation into Clinical Practice. Movement Disorders 30.
Journal Article
49, pp. 1643 - 1654 (2024)
Physical Exercise-Induced Activation of NRF2 and BDNF as a Promising Strategy for Ferroptosis Regulation in Parkinson’s Disease. Neurochemical Research 31.
Journal Article
122, 106078 (2024)
Towards a biological diagnosis of PD. Parkinsonism & Related Disorders 32.
Journal Article
23 (5), e14128 (2024)
Inhibition of 26S proteasome activity by α-synuclein is mediated by the proteasomal chaperone Rpn14/PAAF1. Aging Cell 33.
Journal Article
39 (4), pp. 321 - 328 (2024)
Novel multifunctional nanoliposomes inhibit α-synuclein fibrillization, attenuate microglial activation, and silence the expression of SNCA gene. Neurología (English Edition) 34.
Journal Article
15 (4), 264 (2024)
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death and Disease 35.
Journal Article
31, pp. 3797 - 3804 (2024)
Adsorption of alpha-synuclein and inhibition of fibril formation by nanocellulose and gold-coated-nanocellulose. Cellulose 36.
Journal Article
22, pp. 2670 - 2676 (2024)
Chemical synthesis of site-selective advanced glycation end products in α-synuclein and its fragments. Organic & Biomolecular Chemistry 37.
Journal Article
125 (3), e30523 (2024)
In silico analysis of alpha‐synuclein protein variants and posttranslational modifications related to Parkinson's disease. Journal of Cellular Biochemistry 38.
Journal Article
121 (2), e2309700120 (2024)
Substitution of Met-38 to Ile in γ-synuclein found in two patients with amyotrophic lateral sclerosis induces aggregation into amyloid. PNAS 39.
Journal Article
13 (1), e6900 (2024)
Uncovering potential diagnostic and pathophysiological roles of α-synuclein and DJ-1 in melanoma. Cancer Medicine 40.
Journal Article
147 (1), pp. 81 - 90 (2024)
Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies. Brain